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Abstract
Vertebrate inner ear development is initiated by the specification of the otic placode, an ectodermal structure induced by signals from
neighboring tissue. Although several signaling molecules have been identified as candidate otic inducers, many details of the process of inner
ear induction remain elusive. Here, we report that otic induction is responsive to the level of Hedgehog (Hh) signaling activity in Xenopus,
making use of both gain- and loss-of-function approaches. Ectopic activation of Hedgehog signaling resulted in the development of ectopic
vesicular structures expressing the otic marker genes XPax-2, Xdll-3, and Xwnt-3A, thus revealing otic identity. Induction of ectopic otic
vesicles was also achieved by misexpression of two different inhibitors of Hh signaling: the putative Hh antagonist mHIP and
XPtc1Loop2, a dominant-negative form of the Hh receptor Patched. In addition, misexpression of XPtc1Loop2 as well as treatment of
Xenopus embryos with the specific Hh signaling antagonist cyclopamine resulted in the formation of enlarged otic vesicles. In summary,
our observations suggest that a defined level of Hh signaling provides a restrictive environment for otic fate in Xenopus embryos.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The vertebrate inner ear develops from the otic placode,
an ectodermal thickening emerging at the border between
the neural plate and the future epidermis (reviewed in Baker
and Bronner-Fraser, 2001). To date, little is known about
the molecular events and tissue interactions underlying otic
specification. Otic induction appears to involve signals act-
ing in two different phases of development, at gastrula and
neurula stages (Yntema, 1933, 1950; Gallagher et al., 1996;
Groves and Bronner-Fraser, 2000; Phillips et al., 2001).
Tissues that have been implicated as potential sources of
otic-inducing factors during these stages include the mes-
endoderm and hindbrain, respectively (Yntema, 1950; Men-
donsa and Riley, 1999; Jacobson, 1963). Several members
of the family of fibroblast growth factor (FGF) signaling
molecules were identified as candidate otic inducers in Xe-
nopus, chicken, and zebrafish embryos; these include
FGF-2, FGF-3, and FGF-8. In addition, FGF-19 has also
been proposed to act synergistically with Wnt-8c in otic
induction (Represa et al., 1991; Vendrell et al., 2000; Lom-
bardo and Slack, 1998; Phillips et al., 2001; Ladher et al.,
2000).
Hedgehog (Hh) proteins are secreted signaling factors
that regulate pattern formation of multiple organs and tis-
sues during vertebrate and invertebrate development, e.g.,
the eye, CNS, lung, gut, and limbs. In addition to their
function in cell fate specification, Hh signals control cellular
proliferation in the embryo and in the adult organism (re-
viewed in Taipale and Beachy, 2001). Hedgehog interacting
protein (HIP), a putative transmembrane glycoprotein, was
shown to directly interact with all mammalian Hh proteins
and to negatively modulate Hh activity upon targeted
misexpression in transgenic mice (Chuang and McMahon,
1999; Treier et al., 2001).
Hh signals are thought to be transduced by the combined
action of the multipass transmembrane proteins Patched
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(Ptc) and Smoothened (Smo) (Stone et al., 1996; Marigo et
al., 1996a; Alcedo et al., 1996). Ptc can directly bind to the
Hh ligand, while the putative G-protein-coupled receptor
Smo appears to transmit the signal to the cytosol (Stone et
al., 1996; Marigo et al., 1996a; Chen and Struhl, 1996).
Genetic studies in Drosophila suggested that, in absence of
Hh, a constitutive signaling activity of Smo is inhibited by
Ptc and restored upon binding of Hh to Ptc (Chen and
Struhl, 1996). Ptc was proposed to repress Smo by nega-
tively modulating its stability (Denef et al., 2000). Increas-
ing Smo protein dosage might thus be sufficient to activate
Hh signaling. In contrast to other elements of Hh signaling
diversified in vertebrates, only one vertebrate homologue of
Smo could be identified to date. Emphasizing the central
role of Smo in transducing more than one type of Hh signal
in vertebrates, the phenotypic effects of disrupting Smo
gene function in mice resemble those observed in Shh/Ihh
compound mutants (Zhang et al., 2001). In zebrafish, Smo
was also found to be essential for Hh signaling (Chen et al.,
2001).
We have previously isolated Smoothened (XSmo) and
Patched1 (XPtc1) homologues from Xenopus (Koebernick
et al., 2001). In this study, we examine the patterning
functions of the Hh cascade during early Xenopus embryo-
genesis by misexpression of different activatory and inhib-
itory elements of Hh signaling. We find that modulation of
Hh signaling has stimulatory effects on inner ear develop-
ment in Xenopus embryos. Thus, balanced Hh signaling
activity appears critical for restriction of otic fate specifica-
tion in Xenopus.
Materials and methods
Embryos and whole-mount in situ hybridization
Wild-type and albino Xenopus embryos were obtained
by hormone-induced egg-laying and in vitro fertilization
using standard methods. Whole-mount in situ hybridization
using digoxigenin-labeled antisense RNA probes was per-
formed in principle as described by Harland (1991). Probes
used were: XPax-2 (Heller and Bra¨ndli, 1997), cut with
EcoRI, transcribed with T3 polymerase; XPax-8 (Heller and
Bra¨ndli, 1999), cut with EcoRI, transcribed with T7 poly-
merase, NeuroD (Lee et al., 1995), cut with XbaI, tran-
scribed with T7 polymerase, Xdll-3 (Papalopulu and Kint-
ner, 1993), cut with EcoRI, transcribed with T7 polymerase;
Xwnt-3A (Wolda et al., 1993), cut with ClaI, transcribed
with T7 polymerase; XEya1 (David et al., 2001), cut with
BamHI, transcribed with T7 polymerase; XPtc1 (Koeber-
nick et al., 2001), cut with BamHI, transcribed with T7.
Cyclopamine treatment
After removal of the vitelline membranes at stage 10-11,
embryos were cultivated in the presence of cyclopamine at
a concentration of 20 M in 0.1 MBS (prepared from a
stock solution of 5 mM cyclopamine in 95% ethanol). Con-
trol embryos were treated with 0.38% ethanol.
Embryo microinjections and histology
The full-length ORF of XSmo (GenBank Accession No.
AF302766) fused in frame to a C-terminal FLAG epitope tag
was amplified from embryonic total RNA (stage 21) by
RT-PCR using the linker oligonucleotides Smo_BamHIF
(5-ACTTGGATCCATGTCTTCCATGGTGCCTTG) and
Smo_FLAGXhoIR (5-CCCACTCGAGTTACTTGTCATC-
CTCGTCCTTGTAGTCAAAATCAGAATCTGTAT) and
cloned into the BamHI–XhoI site of the pCS2 expression
vector (Rupp et al., 1994). The expression construct termed
pCS2/XSmo_FLAG was checked by sequencing and in
vitro translation (coupled Transcription/Translation TNT
kit; Promega) in the presence of canine microsomal mem-
branes (Promega) yielding a protein of the expected size (90
kDa) in SDS–PAGE. To produce capped XSmo transcripts,
the plasmid was linearized with NotI and transcribed with
SP6 RNA polymerase (SP6 in vitro transcription kit; Am-
bion). The amino acid substitution W508L in XSmo corre-
sponding to the mutation W535L in human Smo (Smo-M2)
detected in a sporadic basal cell carcinoma and resulting in
constitutive signaling activity of Smo (Xie et al., 1998;
Hynes et al., 2000) was introduced into pCS2/XS-
mo_FLAG by PCR-mediated mutagenesis (QuikChange
site-directed mutagenesis kit; Stratagene). The resulting
construct was referred to as XSmo-M2.
Xshh (Ekker et al., 1995) and NLSLacZ (Chitnis et al.,
1995). RNAs were prepared as originally described. The
full-length ORF of mouse HIP was amplified by PCR
(Chuang and McMahon, 1999) and inserted into the
BamHI–XhoI sites of pCS2. The construct was checked
by sequencing. To produce capped XSmo transcripts, the
plasmid was linearized with NotI and transcribed with SP6
RNA polymerase (SP6 in vitro transcription kit; Ambion).
The full-length ORF of XPtc1 (GenBank Accession No.
AF302765) was inserted into the 5XhoI/3XbaI sites of
pCS2 in several steps of PCR-mediated amplification by
using Pfu-Polymerase (Stratagene). During the cloning pro-
cedure, a 5-nucleotide insertion (GCACA at nucleotide po-
sition 2642) in the original cDNA causing a frameshift muta-
tion was eliminated. The resulting construct termed pCS2/
XPtc1 was checked by sequencing and in vitro translation
(TNT; Promega) in the presence of canine microsomal mem-
branes yielding a 150-kDa protein product. The mutant
XPtc1Loop2 corresponding to a dominant-negative form of
Patched (Briscoe et al., 2001) was constructed by amplification
of a cDNA-segment flanking the sequence coding for amino
acids 798-1001 of pCS2/XPtc1 with the oligonucleotides
XPtc1L2_F 5-TCGAGCGTACTAGTTGGCTACCCTT-
TCCCTGTTCTGGGAGCAATAC and XPtc1L2_R 5-
TCATTTTACCACATGTATGTGGTTACAGTACTAGTT
GACTAC using the QuikChange site-directed mutagenesis
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kit (Stratagene). The fused amino acid sequence flanking the
deletion is SFYHMYVVTvlvGYPFLFWQYI (inserted
amino acids are printed in italics) and was checked by
sequencing. Capped mRNA was synthesized with SP6 RNA
polymerase from pCS2/XPtc1Loop2 linearized with
NotI (SP6 in vitro transcription kit; Ambion). RNAs were
injected in a volume of 5 nl at concentrations of up to 400
pg/nl either alone or together with 10 pg/nl of LacZ RNA
into one or two blastomeres of Xenopus embryos at the
two-, four-, or eight-cell stage. Embryos were collected at
appropriate stages and subjected to whole-mount in situ
hybridization as described above.
Vibratome sections (30 m) were prepared from gelatin-
embedded embryos as described previously (Hollemann et
al., 1996).
Results
XSmo mimics the effect of Shh on the organization of the
visual system
Shh expressed in the prechordal plate is essential for the
bilateralization of the eye field and its subsequent proximo-
distal patterning into optic stalk and optic cup tissues. Shh-
deficient mice exhibit a single cyclopic eye vesicle com-
pletely devoid of Pax-2-positive optic stalk tissue, whereas
zebrafish embryos overexpressing Shh develop hypertro-
phic optic stalks expressing elevated levels of Pax-2 at the
expense of retinal tissue (Chiang et al., 1996; Macdonald et
al., 1995; Ekker et al., 1995). In Xenopus, pigmentation of
the retinal epithelium (RPE), the distal-most structure of the
optic cup, first appears during late tailbud stage (st. 34-36).
The most prominent phenotypic effect we could observe
upon injection of XSmo mRNA into one cell of the two-
cell-stage embryo was a strong reduction of RPE differen-
tiation in the eye that was often accompanied by an abnor-
mal eye morphology (Table 1; Fig. 1B and C). This
phenotype could already be detected at low doses of mRNA
(50 pg/embryo), with increasing frequency at higher doses
(0.375-1 ng/embryo). A similar phenotype was obtained
upon overexpression of XShh (not shown). The observed
dose-dependency of the phenotypic effects induced by
XSmo can well be reconciled with the idea of an inherent
XSmo signaling activity that becomes apparent only after
protein doses exceed a certain threshold level required to
overcome inhibition by endogenous XPtc. To assess for the
effect of constitutive activation of XSmo in Xenopus, a
mutant was constructed that corresponds to the human mu-
tation Smo-M2 (Hynes et al., 2000; Xie et al., 1998). As
predicted, this single amino substitution (W508L in XSmo)
considerably increased the frequency of the phenotype (Ta-
ble 1).
We also analyzed whether the observed repression of
distal eye fate correlates with induction of proximal eye
fate, as reflected by ectopic XPax-2 expression. Ectopic
XShh induces expanded expression of XPax-2 throughout
the entire optic vesicle (Fig. 1G). Misexpression of XSmo
similarly results in an expansion of XPax-2 expression into
the region of the optic vesicle, that did, however, in no
instance include the whole optic vesicle and was observed at
a lower frequency (Fig. 1E). Conversely, after misexpres-
sion of XSmo-M2, XPax-2 was expressed throughout the
optic vesicle in all embryos analyzed, again reflecting rein-
forcement of XSmo activity by the mutation (Fig. 1F). In its
capacity to induce proximal eye structures and to simulta-
neously repress the differentiation of distal eye elements,
XSmo thus exhibits a patterning activity similar to Shh.
Misexpression of XSmo induces ectopic otic vesicles
expressing XPax-2, Xdll-3, and Xwnt-3A
Pax-2 is essential for the proper development of the
cochlea, the ventral part of the inner ear (Torres et al.,
1996). While investigating XPax-2 expression in embryos
injected with XSmo, we noticed formation of ectopic struc-
tures expressing XPax-2 that, because of their spherical
shape, closely resembled otic vesicles (Fig. 2B–E, arrow-
heads). Ectopic XPax-2 expression domains varied in size
and were detectable as small spots, as tiny spherical struc-
tures, and sometimes even reaching the normal size of otic
vesicles. Such multiple, small domains of ectopic XPax-2
expression were frequently positioned lateral to the neural
tube, but never to the more ventral regions of the embryo.
Vesicular structures of normal size only occurred individu-
ally and in close proximity to the orthotopic otic vesicle. A
horizontal section of one of these larger ectopic structures
confirms its vesicular morphology (Fig. 2F).
To elucidate whether these ectopic vesicles express other
marker genes indicative of otic specification, we analyzed
the expression of the early otic marker genes Xdll-3 and
Xwnt-3A in the manipulated embryos (Fig. 3). The ho-
meobox gene Xdll-3, representing the Xenopus orthologue
of the Dlx-5 gene (Papalopulu and Kintner, 1993), defines
one of the earliest markers of the otic placode. Dlx-5 is
required for normal development of the semicircular canals
Table 1
Phenotypic effects of XSmo misexpression in Xenopus embryos
Sample Injected
blastomere
RNA
injected
(ng)
st. N n Reduced
RPE
(%)
XSmo 1/2 a 0.05 36 1 98 35
1/2 a 0.125 36 1 93 47
1/2 a 0.25 36 1 113 35
1/2 a 0.375 36 1 109 62
1/2 a 0.5 36 2 168 57
1/2 a 1 36 2 155 61
1/2 a 2 36 1 71 41
XSmo-M2 1/2 a 1.5 36 1 70 100
Note. a, animal; N, number of experiments; n, number of embryos; RPE,
retinal pigmented epithelium; st., analyzed stage.
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Fig. 2. XSmo induces ectopic otic vesicles expressing XPax-2. Embryos injected with XSmo mRNA (1.5 ng) into one of two blastomeres were fixed at
embryonic stage 36 and stained for XPax-2 expression (purple) by whole-mount in situ hybridization. Lateral (A–C, E) and dorsolateral (D) views of injected
embryos showing ectopic vesicular structures expressing XPax-2 in -galactosidase-positive (light blue) manipulated sides (arrowheads, 12%, n  50). (F)
Horizontal vibratome section of the embryo shown in (D) at the level of the otic vesicles revealing the vesicular morphology of the ectopic otic vesicle. The
single otic vesicle of the noninjected side appeared in a section plane localized more ventrally (not shown).
Fig. 1. Effect of XSmo on the proximodistal patterning of the visual system. Lateral view of the head region of embryos (st. 36) injected with mRNAs
encoding XSmo (1.5 ng; A, B, D, E), XSmo-M2 (1.5 ng; F), or Shh (500 pg; G) into one of two blastomeres. (C) Transverse vibratome section of an
XSmo-injected embryo at the level of the optic vesicles. (D–G) XPax-2 expression (purple) in manipulated embryos detected by whole-mount in situ
hybridization. In (E) and (G), injected sides (is) were identified by -galactosidase staining (light blue). (H) In situ hybridization revealing ectopic XPtc1
expression in embryos injected unilaterally (one of two blastomeres) with mRNAs coding for XSmo (H, 1.5 ng, 86%, n  28 embryos). is, injected side;
nis, noninjected side; ov, optic vesicle; rpe, retinal pigmented epithelium.
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of the inner ear derived from the dorsal part of the otocyst
(Depew et al., 1999; Acampora et al., 1999). At tailbud
stage, Xdll-3 is expressed in the forebrain, the cement gland,
branchial arches, and the otic vesicle, and the ectopic ve-
sicular structures forming upon XSmo injection also express
Xdll-3 (Fig. 3B, E, and F). Misexpression of XSmo-M2 (1.5
ng/embryo) results in a slightly enhanced effect. Another
otic marker gene, Xwnt-3A, is expressed exclusively in the
dorsal part of the otic vesicle (Wolda et al., 1993). Embryos
injected with XSmo also exhibit ectopic expression of
Xwnt-3A (Fig. 3D, G, and H). Taken together, ectopic ve-
sicular structures induced by XSmo express a number of
different otic marker genes.
Effects of Hh signaling antagonists on otic specification
in Xenopus
Hedgehog interacting protein (HIP) is a putative trans-
membrane glycoprotein that was shown to directly interact
with vertebrate Hh proteins and was found to antagonize Hh
signaling upon targeted misexpression in transgenic mice
(Chuang and McMahon, 1999; Treier et al., 2001).
To examine the effect of inhibition of Hh signaling on
otic specification in Xenopus, murine HIP was misexpressed
in Xenopus embryos by means of mRNA injection, and
injected embryos were monitored for XPax-2 and Xdll-3
expression. Surprisingly, ectopic otic vesicles expressing
Xdll-3 appeared in a fraction of embryos injected with
mHIP (Fig. 4B–E). Ectopic XPax-2 expression was also
detected in mHIP-injected embryos (Fig. 4F and G).
To address the question, if the effects induced by XSmo
and mHIP were indeed consequences of ectopic activation
or repression of Hh signaling, manipulated embryos were
investigated for Xenopus Ptc1 (XPtc1) expression. In dif-
ferent vertebrate model systems, Ptc1 defines a direct tran-
scriptional target of Shh signaling (Goodrich et al., 1996;
Marigo and Tabin, 1996; Marigo et al., 1996b). As ex-
pected, XPtc1 expression was activated by XSmo with high
efficiency (Fig. 1H). As already suggested by the effects on
ocular patterning, overexpression of XSmo thus appears to
be sufficient for ectopic activation of the Hh signaling
cascade. In contrast, the majority of mHIP-injected embryos
displayed a strong reduction of XPtc1 expression (Fig. 4A).
Although the downregulation of XPtc1 in the majority of the
embryos suggests that mHIP inhibits Hh signaling in Xeno-
pus, manipulated embryos never developed cyclopia upon
injection of mHIP into both cells of the two-cell stage (not
shown). Thus, we do not appear to achieve complete inhi-
bition of Shh signaling by misexpressing mHIP.
To determine whether misexpression of XSmo and
mHIP interfered with otic placode specification at the cor-
responding time during development, the spatial expression
of the early placodal marker gene XEya1 was examined in
manipulated neurula-stage embryos (Fig. 5). Eya1 is essen-
tial for ear development in humans and mice (Abdelhak et
al., 1997; Xu et al., 1999), while the zebrafish Eya1 mutant
dogear only shows abnormal ear morphogenesis (Whitfield
et al., 2002). At neurula stage, XEya1 is expressed in bilat-
eral, ectodermal domains at the margin of the neural plate,
which comprise the precursors of lateral line, otic, and other
Fig. 3. Ectopic otic vesicles express the otic marker genes Xdll-3 and Xwnt-3A. Head region of embryos (st. 36) injected with XSmo (B, E, D, G, H) or
XSmo-M2 (F) mRNA (1.5 ng/embryo each, one of two cells) and stained for Xdll-3 (A, B, E, F) or Xwnt-3A (C, D, G, H) expression. Ectopic vesicles in
XSmo-injected embryos expressed Xdll-3 (29%, n  27) and Xwnt-3A (16%, n  31). Ectopic vesicles expressing Xdll-3 also appeared in XSmo-M2-injected
embryos (F, 38%, n  26). is, injected side; nis, noninjected side.
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placodes (David et al., 2001). The manipulated side of
embryos injected with either XSmo (Fig. 5A) or mHIP (Fig.
5B) exhibited elevated and slightly expanded XEya1 expres-
sion in the preplacodal region. Therefore, the effects in-
duced by misexpression of XSmo and mHIP might arise
from early alterations in the embryonic region committed to
give rise to the otic placode.
To further elucidate whether these alterations specifically
affected the otic placode territory, XSmo- and mHIP-in-
jected neurula-stage embryos were also monitored for the
Fig. 4. Effects of mHIP on XPtc1 expression and otic specification. Following injection of mHIP mRNA (750 pg) into one of two blastomeres, embryos were
fixed at stage 38 (A) or stage 36 (B–G) and stained for expression of XPtc1 (A), Xdll-3 (B–E), or XPax-2 (F, G). mHIP-injected embryos (n  24) exhibit
strongly reduced XPtc1 expression (74%; A). In parallel, ectopic vesicular structures (depicted by triangles) expressing Xdll-3 (27%, n  22) and XPax-2
(10%, n  31) were also observed in mHIP-injected embryos. is, injected side; nis, noninjected side.
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expression of XPax-8, the earliest specific marker gene for
the otic placode in vertebrates (Heller and Bra¨ndli, 1999).
Apart from a dorsolateral domain demarcating the preotic
territory, XPax-8 expression is also found in a more poste-
rior domain corresponding to the pronephros anlage (Fig.
5F). In XSmo-injected embryos, XPax-8 expression in the
Fig. 5. Misexpression of XSmo and mHIP alters the expression of the placodal marker genes XEya1 and XPax-8. Two-cell-stage embryos were injected into
one blastomere with XSmo (A, C, D) mRNA (1.5 ng) or mHIP (B, E–G) mRNA (B, 750 pg; E–G, 500 pg), fixed at early neurula stages (13-14) and analyzed
for XEya1 or XPax-8 expression (purple). Embryos are shown in dorsal view in (A) and (C–E) (anterior is down), anterior view in (B) and lateral view in
(F) and (G) [anterior is right (F) or left (G)]. Embryos in which XEya1 or XPax-8 signals overlapped with -galactosidase-positive regions (light blue) were
analyzed. Manipulated embryos exhibited enhanced and expanded XEya1 expression in the preplacodal region (XSmo: 59%, n  22; mHIP: 60%, n  25).
Posterior expansion and enlargement of the XPax-8-positive preotic domain (located anteriorly) was observed in 57% (n  28) and 53% of XSmo-injected
embryos, respectively (C), with a concomitant reduction of pronephric XPax-8 expression (C, 46%, n  28). The pronephric and the preotic domain merged
in 18% (n  28) of XSmo-injected embryos (D) and in 60% (n  10) of mHIP-injected embryos (E, F). In a subset of mHIP-injected embryos, an expansion
of the preotic domain (40%, n  10) and a reduction of the pronephric domain (20%, n  10) were also observed (not shown). Representative examples
are shown for each injected construct. is, injected side; nis, noninjected side.
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prospective otic placode appeared to be enlarged and ex-
panded posteriorly with a concomitant reduction of XPax-8
expression in the prospective region of the pronephros an-
lage (Fig. 5C). In a further subset of XSmo-injected em-
bryos, the preotic and pronephric domain appeared to be
merged into a single domain (Fig. 5D). In mHIP-injected
embryos, XPax-8 expression also appeared as single, indis-
tinguishable domain (Fig. 5E and G), while an expansion of
the preotic domain and a reduction of the pronephric do-
main occurred in fewer cases (not shown). Thus, both
XSmo and mHIP have profound, partially overlapping ef-
fects on the organization of the otic placode.
Next, we addressed the question, if other placodal deriv-
atives were also affected by misexpression of XSmo or
mHIP. The otic vesicle and the lateral line system appear to
originate from a common preplacodal area in Xenopus
(Schlosser et al., 2000). In Xenopus, NeuroD is expressed in
the neurogenic part of all neurogenic placodes, including the
five lateral line placodes and the epibranchial placodes (Lee
et al., 1995; Schlosser et al., 2000). High doses of injected
XSmo mRNA (2 ng/embryo) strongly disrupted and re-
duced all placodal domains of NeuroD expression (Fig. 6B).
Lower doses of injected XSmo mRNA (1.5 ng/embryo)
resulted in mild alterations of placodal morphology (Fig.
6D). Interestingly, the presumptive territories of the ganglia
extending from the epibranchial placodes VII and IX ap-
peared to converge in a high percentage of XSmo-injected
embryos (Fig. 6D). Misexpression of mHIP also disrupted
NeuroD expression (Fig. 6F) albeit in a less pronounced
manner. Thus, the induction of the ectopic otic structures by
XSmo or mHIP might occur at the expense of other neuro-
genic placodes, including the lateral line placodes.
A deleted form of the Hh receptor Patched (Ptc) lacking
the second extracellular domain (Ptc1Loop2) was recently
reported to block Hh signal transduction in the neural tube
of chick embryos and Drosophila wing blades (Briscoe et
al., 2001). To take a different approach to inhibit Hh sig-
naling in developing Xenopus embryos, we constructed a
corresponding deletion mutant of Xenopus Patched1,
termed XPtc1Loop2. Misexpression of full-length XPtc1
did not evoke considerable morphological alterations in
injected Xenopus embryos irrespective of the amount of
injected mRNA. In contrast, embryos injected with high
doses of XPtc1Loop2 mRNA exhibited neural tube clo-
sure defects at high frequencies. Importantly, injection of
moderate amounts of XPtc1Loop2 mRNA induced the
formation of ectopic otic vesicles expressing Xdll-3 in ma-
nipulated embryos (Fig. 7A–E). Thus, in addition to mHIP,
another inhibitor of Hh signaling exhibited a stimulatory
effect on otic induction in Xenopus embryos. Apart from
this, orthotopic otic vesicles appeared to be enlarged in
XPtc1Loop2-injected embryos (Fig. 7E).
Finally, the teratogen cyclopamine also specifically in-
hibits Hh signaling, possibly by directly interfering with
Smo signaling activity (Taipale et al., 2000). After applica-
tion of cyclopamine, enlarged otic vesicles were observed in
treated embryos (Fig. 7G). In contrast, control embryos
treated with 0.38% ethanol did not show enlarged otic
vesicles (Fig. 7F). Taken together, these observations sug-
gest that endogenous Smo activity could function to restrict
the territory of the otic primordium.
Discussion
In the present study, we have examined the patterning
functions of Hh signaling during Xenopus embryogenesis
by interfering at different levels with the Hh signal trans-
duction cascade. The transmembrane receptor Smo has been
proposed to act as constitutively active transducer of Hh
signaling. XSmo misexpression was found to phenocopy
the effect of Shh on the organization of the visual system
and to activate XPtc1 expression. These observations are
consistent with a function of XSmo as mediator of Hh
signaling in Xenopus. Increased XSmo protein levels appear
to be sufficient to activate Hh signaling in Xenopus. There-
fore, our results also support the idea of an intrinsic signal-
ing activity of Smo. However, the overexpression construct
used in our experiments contains an octameric FLAG
epitope tag fused to the C terminus of XSmo and thus we
cannot exclude the possibility that this tag fusion could
modify XSmo activity, e.g., by stabilizing the protein. In
other studies, misexpression of WT Smo by itself failed to
elicit activation of the Hh pathway (Hynes et al., 2000;
Ingham et al., 2000). Alternatively, the protein levels of WT
Smo attained in these experiments may have been too low to
fully overcome inhibition by Ptc. However, the human
Smo-M2 protein was reported to activate Hh target genes
cell-autonomously (Hynes et al., 2000). We also observed a
clearly increased activity of XSmo-M2. Compared with WT
XSmo, the phenotypic effects induced by XSmo-M2 at the
same dose of injected mRNA were observed with higher
frequency, possibly reflecting the reduced sensitivity of this
mutant towards inhibition by Ptc.
In addition to the effects observed in the optic primor-
dium, misexpression of XSmo in Xenopus embryos was
found to induce the formation of ectopic vesicular structures
expressing the otic marker genes XPax-2, Xdll-3, and Xwnt-
3A, thus revealing an otic identity. The embryonic region in
which ectopic otic vesicles occurred was restricted to head
and ectoderm lateral to the neural tube. A similar distribu-
tion of ectopic otic vesicles was reported by Vendrell et al.
(2000) in chick embryos misexpressing FGF-3 and in Xe-
nopus embryos treated with lithium (Gutknecht and
Fritzsch, 1990). Thus, similar regions appear to be respon-
sive to otic induction in Xenopus and the chick. Interest-
ingly, the lateral line system and the otic vesicle were
proposed to originate from a common preplacodal region
(Coombs et al., 1989; Schlosser et al., 2000). We observed
that high levels of both mHIP and XSmo could interfere
with the development of lateral line placodes, as evidenced
by a reduction of NeuroD expression. Imbalanced Hh sig-
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Fig. 7. Effect of XPtc1Loop2 and cyclopamine treatment on otic specification. (A–E) Embryos were injected with XPtc1Loop2 mRNA (750 pg) into one
of two cells, fixed at stage 36, and stained for Xdll-3 expression. Embryos injected with XPtc1Loop2, a dominant-negative form of XPtc1, exhibit ectopic
vesicular structures expressing Xdll-3 (31%, n  36) (indicated by arrows) and enlarged otic vesicles (E). (F) Normal-sized otic vesicle in control embryo
treated with 0.38% ethanol (100%, n  10). (G) Enlarged otic vesicle developed upon treatment with 20 M cyclopamine (50%, n  8). Con, control; cyc,
cyclopamine; is, injected side; nis, noninjected side.
Fig. 6. Lateral line placodes are disrupted in XSmo- and mHIP-injected embryos. Embryos were injected with XSmo mRNA (1.5 ng, C, D; or 2 ng, A, B)
or mHIP mRNA (500 pg, E, F) into one blastomere of the two-cell stage, fixed at stage 28, and analyzed for NeuroD expression. High doses of injected XSmo
mRNA resulted in a strong disruption and reduction of the NeuroD-expressing placodal region (B, 44%, n  18) Convergence of ganglia from the
epibranchial placodes VII and IX (D, arrow) was observed in 33% (n  21) of embryos injected with low doses of XSmo mRNA. NeuroD expression was
also disrupted in 64% (n  25) of mHIP-injected embryos (F). epVII, facial epibranchial placode; epIX, glossopharyngeal epibranchial placode; epX1, first
vagal epibranchial placode; expX2/3, fused second and third vagal epibranchial placode; pAD, anterodorsal lateral line placode; pM, middle lateral line
placode; pP, posterior lateral line placode; is, injected side; nis, noninjected side.
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naling might thus favor a commitment of this primordium
towards an otic fate at the expense of lateral line fate.
Induction of ectopic otic vesicles was also achieved by
two independent approaches aiming to inhibit Hh signaling
in Xenopus embryos: misexpression of the Hh antagonist
mHIP and XPtc1Loop2, a putative dominant-negative
form of XPtc1. Both positive and negative modulation of
Hh signaling thus appeared sufficient to induce ectopic
inner ear development in Xenopus embryos. XSmo and
mHIP also enhanced and expanded XEya1 expression in the
preplacodal region. Therefore, the otic inducing effects of
XSmo and mHIP appear to be initiated at a stage coinciding
with the specification of the preotic field. Interestingly, Hh
signaling is required for eya expression in Drosophila (Cur-
tiss and Mlodzik, 2000).
To date, only few experimental findings imply a connec-
tion between Hh signaling and otic development. Sensori-
neural hearing loss that might indicate inner ear defects was
reported in a holoprosencephaly patient revealing a trans-
location of the Sonic hedgehog gene (Belloni et al., 1996).
Recently, disturbed inner ear morphogenesis was also re-
ported in Shh-deficient mice (Liu et al., 2002; Riccomagno
et al., 2002). However, Shh is not required for otic induction
in mice. Indirect evidence argues in support of an involve-
ment of Hh signaling in otic development in Xenopus;
Xrel3, a member of the Rel protein family, is expressed in
the otic placode of neurula embryos and later in the otocyst
(Yang et al., 1998). Misexpression of Xrel3 could induce
ectopic expression of Shh and Gli1, indicating a function of
Xrel3 upstream of Hh signaling (Lake et al., 2001). More-
over, a dominant-negative form of Xrel3 (Xrel358) inhib-
its expression of Shh, Otx2, and Gli1 and strongly disrupts
anterior development. In addition, Xrel358-injected em-
bryos developed abnormal otocysts (Yang et al., 1998).
It seems difficult to understand that both positive and
negative modulation of Hh signaling result in common
effects on otic specification. One possible interpretation of
these findings is that a certain level of Hh signaling might be
required to restrict the correct spatial assignment of otic
placode identity. A parallel situation might be reflected in
effects obtained by alterations of retinoic acid levels (RA) in
developing embryos. Elevation of RA levels by application
of RA to zebrafish embryos results in the formation of
ectopic otic vesicles (Phillips et al., 2001). Moderate reduc-
tion of RA levels in rats held on a Vitamin A-deficient diet
also causes the development of ectopic otic vesicles (White
et al., 2000). Hh and RA signaling interact during the
development of facial structures and limb buds (Schneider
et al., 2001; Akimenko and Ekker, 1995). Since Smo has
been proposed to exist in a balance of active and inactive
states (Taipale et al., 2000), it might however also be pos-
sible that inactive forms of XSmo coexist in injected em-
bryos and account for the similarity of the effects to those
obtained by inhibition of Hh signaling. Induction of XPtc1
expression by activation of Hh signaling is predicted to
result in feedback inhibition of Smo activity, which may
occur only partially. Cyclopamine is predicted to inhibit
endogenous Smo activity. The effects of cyclopamine and
dominant-negative XPtc1 (XPtc1Loop2) on otic vesicle
size imply that a particular, preexisting level of Smo activity
restricts otic field specification at its proper site. Above this,
induction of ectopic otic vesicles by XPtc1Loop2 and HIP
implies that the restrictive influence of Hh signaling on otic
specification also comprises other preplacodal territories.
Enlargement of orthotopic otic vesicles was not achieved by
mHIP injection, which might possibly reflect a limited ac-
tivity of this murine protein in Xenopus. We did not achieve
cyclopic phenotypes in any of our experiments inhibiting
Hh signaling. Maybe these experimental approaches did not
interfere with Hh signaling effectively at the time when
bilateralization of the eye field occurs (late gastrula stage).
Taken together, we propose that a particular level of Hh
signaling activity restricts otic field specification in Xeno-
pus. Since it has been demonstrated that Shh can act as a
long-range signal (Zeng et al., 2001), it appears conceivable
that Shh signals secreted from the midline could establish
this level of signaling activity in the bilateral preplacodal
ectoderm. According to this model, this level would be
predicted to be reduced at the position of the otic primor-
dium. In the next step, it will be interesting to determine at
which level Hh signaling might influence the activity of otic
inducers during the sequence of events leading to otic spec-
ification. For instance, spatiotemporal expression of an otic-
inducing signal might depend on a reduced level of Hh
signaling activity. Alternatively, an otic-inducing signal
may itself downmodulate the level of Hh signaling activity
and initiate otic induction.
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